Loading...

CALC CALCIMEDICA INC Product Launches 8-K Filing

CLCM

CLC

CALCIMEDICA INC

(CALC)

2026 8-K

NASDAQ Compliance Issues

Financial Results Announcement

Trial Discontinued

Trial Discontinuation

Quarterly Financial Results

Stock Offering Update

Equity Offerings

Financial Statements

Financial Results

Clinical Trial Results

Stock Offering Update

Financial Results

Management Change

Financial Update

Positive Trial Results

Equity Plan Update

Financial Results

Phase 2b CARPO Trial Toplin...

Financial Results Announcement

Dismissal of Independent Re...

Increase in Offering Price

Financial Results Announcement

Regulation FD Disclosure an...

Amendment to Private Placement

Private Placement

Financial Results Announcement

Financial Condition and Oth...

Updated Business Description

Financial Results and Annua...

Annual Meeting Date Set

Regulation FD Disclosure

Earnings Reports

Restatement of Financial St...

Merger of Equals

Termination of Employment

Director Appointments and R...

External Links:

On January 28, 2026, CalciMedica, Inc. announced the stoppage of its Phase 2 KOURAGE clinical trial due to a recommendation from the Independent Data Monitoring Committee, along with an updated financial outlook indicating enough funds to operate into Q4 2026, compared to previous guidance of H2 2026.

AI Assistant

CALCIMEDICA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.